Alastin C‑Radical Defense Antioxidant Serum
ALASTIN Skincare, part of Galderma, has launched C-RADICAL Defense Antioxidant Serum in the UK, expanding its professional skincare portfolio with a vitamin C-based antioxidant serum for daily skin defence.
The serum uses an encapsulated form of sodium ascorbate, delivered through a proprietary liposomal system, rather than traditional L-ascorbic acid. The formulation also contains 14 additional antioxidants, including lactoferrin, ergothioneine, green tea extract, ectoin and coenzyme Q10, targeting oxidative stress linked to UV exposure, pollution, blue light and other environmental stressors.
ALASTIN positions the serum as a daily restorative product designed to support smoother, brighter-looking skin while helping to conserve elastin. Product data from Galderma reports that the formula helps reduce the effects of free radicals in the skin by up to 74%, with a 12-week clinical study showing visible improvements in texture, tone, luminosity, fine lines, wrinkles and photodamage from as early as eight weeks.
For clinics, the launch taps into the growing demand for professional homecare that supports broader skin quality programmes. Antioxidant serums are already a core recommendation in many aesthetic and advanced skin treatment plans, but ALASTIN’s focus on elastin conservation gives the product a clearer clinical positioning for practitioners treating photodamage, ageing-related laxity and compromised skin resilience.
Rene Wipperich, Galderma UK&I general manager, said, “We are thrilled to announce the UK launch of the ALASTIN C-Radical Defense Antioxidant Serum, a skincare innovation that reflects both science and sensibility. This launch marks the next step in delivering visible results with trusted ingredients, responding directly to evolving consumer expectations while reinforcing our commitment to quality, efficacy, and overall long-term skin health.”
Available through selected ALASTIN skincare providers in the UK.
Pigmentation rarely has a single cause, which makes treating it with a single ingredient something of a hopeful exercise. HydroPeptide is taking a broader approach with Syner-C+ Multi-Action Brightening Serum, a new daily treatment designed to address discolouration at several points in the pigment-forming process. The serum expands the professional skincare brand’s Brighten Collection and combines a 20 per cent concentration of the stable vitamin C derivative 3-O Ethyl Ascorbic Acid with tranexamic acid, arbutin, niacinamide and HydroPeptide’s patented Micellar CellRenew-16 peptide technology.